Screening for lower genital tract pathogens in the ob patient

Philip B. Mead, Sharon Hillier, Helen McDonald, James A. McGregor, Richard L Sweet

Research output: Contribution to journalArticlepeer-review


New molecular amplification tests may soon simplify screening for entities like Chlamydia and Neisseria gonorrhoeae, and the CDC's new protocol for GBS screening in pregnancy is now standard. But who and when to test for Trichomonas, Mycoplasma, and BV remain at issue. Here, five experts from the Infectious Diseases Society for Obstetrics and Gynecology review the data and offer their recommendations for clinical practice today.

Original languageEnglish (US)
Pages (from-to)126-145
Number of pages20
JournalContemporary Ob-Gyn
Issue number5
StatePublished - 1997
Externally publishedYes

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Screening for lower genital tract pathogens in the ob patient'. Together they form a unique fingerprint.

Cite this